An invite-only script is a TradingView indicator or strategy whose author decides, username by username, who can run it. That is the whole definition. It says nothing about what the script does, whether it works, or whether anyone has checked. Because the phrase turns up most often in sales pages and in the panel of a chart where an indicator refuses to appear, it has picked up connotations it does not carry. This post sets out what the setting controls, what it leaves untouched, and which questions are worth asking before paying for access to one.
Everything below describes TradingView's publishing model at the time of writing. The distinctions between the modes are the durable part.
Scripts on TradingView are written in Pine Script, and an author who wants other people to run one has to publish it. There are three publication modes, differing in what the reader can see and who can add the script to a chart.
An open-source script shows its full code to anyone, and anyone can add it. A protected script hides the code but can still be added by anyone who finds it in the community library. An invite-only script hides the code and is added only by accounts the author has placed on an access list. There is also a fourth state that is not a publication at all: a script saved but never published runs only on the author's own account.
Invite-only is therefore the mode that hides the most and grants the least by default. It suits an author who charges for access and equally one who wants to limit distribution for any other reason, such as a script still being tested with a small group. The setting does not distinguish between them.
The access list is the mechanism. The author enters TradingView usernames, and the script appears in the Invite-only scripts section of the Indicators panel for those accounts and nowhere else. Access is matched to the username as written, which is why a single mismatched character is the most common reason the section stays empty. It can also carry an expiry date, so a trial or a lapsed subscription ends by the script disappearing from the panel rather than by anything happening on the chart.
Two consequences follow. Access is per account, not per chart or device: once granted, the script is available on any chart that account opens. And the author can revoke it, which is what makes subscription pricing workable on the platform. For the Behavioral Transform Model, the FAQ page describes the handover in three steps and gives the activation window, and what the model is and how it is obtained has the fuller account.
Invite-only is not a mark of review. TradingView applies house rules to anyone selling access to a script, and those rules concern conduct and presentation; they are not a test of whether the indicator's claims hold up. An open-source script and an invite-only script have been checked to the same degree, which is to say the platform has checked neither one's claims.
Invite-only is not a quality signal in either direction. Careful and careless scripts exist in every mode. The setting tells the reader how distribution is handled and nothing about what is being distributed.
Invite-only is not the same as private. A private script has never been published and runs only on its author's account. An invite-only script has been published, has a listing and a description, and can be granted to anyone the author chooses. The two are often conflated because both keep the code hidden.
And invite-only does not restrict what the script can do. The Pine Script functions available are the same in every mode, including the ones that make a script repaint, meaning that its historical output changes after the fact. Whether a script repaints is a property of how it was written, not of how it was published, and hidden code means the reader cannot check it by reading. The How It Works page states the relevant property for the Behavioral Transform Model in one sentence: once a bar closes, its range and markers are fixed and never change afterward; only the live marker on the forming bar can update until the close.
The honest reason most authors give is the obvious one: public code can be copied, and an author who has done real work may not want to give it away. That is a legitimate position, and hiding the code is not in itself suspicious.
What hiding the code changes is where the burden of evidence sits. With an open-source script the reader can, in principle, work out what it claims by reading it. With an invite-only script that route is closed, so the only things left to evaluate are what the author says the script does and whatever evidence the author publishes for it. If the author publishes nothing beyond a description and some screenshots, there is nothing to evaluate. That is not a failure of the format; it is what the format leaves to the author to supply.
This is the position Oisigma took in choosing invite-only distribution: hide the implementation, publish the claim and the evidence for it instead. The construction of the band, the data it was measured on, the containment figures, the misses and the crisis-onset limit are set out in the working paper, and the reasoning is the subject of why we publish our methodology. Whether that trade is a good one is for the reader to decide, but it is the trade the format invites.
Because the mode hides the code, the useful questions are about the claim rather than the implementation. They are the same questions the evidence-led shortlist of band indicators applies to public and private scripts alike.
What, precisely, does the script claim? A band implies that the next close should usually land inside it; a signal script implies that its signals have some property. A claim that cannot be stated cannot be tested. Has the claim been measured, on what data, and how did it come out? For the Behavioral Transform Model the answer is on the Proof page: across 40 instruments in five asset classes on daily bars, the inner band contained about 71% of next closes historically and the outer band about 94%, reported alongside the stretches where it fell short. Past behavior is not a guarantee of future results; a published figure describes a record, not the next bar. Most invite-only listings publish no figure of that kind, which is not a claim that they fail, only that the reader cannot check.
Does the output stay fixed once a bar closes? If the author does not say, the question is worth asking directly. Can the claim be checked on the reader's own data? A containment claim can be re-run in a spreadsheet from exported closes, as how to backtest a band indicator on your own data walks through; a claim that cannot be re-run from its description is one the reader is being asked to take on trust.
One thing the evidence does not settle, for any script, is whether using it makes money. The paper behind the Behavioral Transform Model validates the range's calibration, not the profitability of any use of it, and whether any use delivers value after costs is an open question the calibration work does not address. A script that answers that question in its sales copy, with a number, is making a claim the reader should ask to see the test for.
Invite-only is a publication setting. It puts the author in control of who can run the script and keeps the code hidden; it carries no review, no quality mark and no restriction on what the script can do. Because the code is hidden, showing what the script claims and whether the claim holds falls entirely to the author, and the reader's job is to ask for it.
Why don't I have an Invite-only scripts section in my Indicators panel? Because the section appears only once an author has granted at least one script to the account; an account that holds no access shows no section at all. If access was expected and the section is missing, the usual cause is that it was granted to a username that differs from the one logged in, since usernames are matched as written. For the Behavioral Transform Model the FAQ page gives the typical activation window and the address to write to if it stalls.
Can I see the code of an invite-only script? No. Invite-only and protected scripts both hide their source; only open-source scripts show it. What can be read is the listing's description and whatever the author has published about the method outside the platform. For the Behavioral Transform Model the construction is specified in full in the working paper, so the method is public even though the Pine implementation is not.
Does an invite-only indicator work on TradingView's free plan? Access to an invite-only script is granted by its author, not by TradingView's plan tier, so the free plan can run one. The paid tiers change how many indicators a chart can hold at once and which intraday timeframes are available, which is a platform limit that applies to every indicator equally. The FAQ page states this for the Behavioral Transform Model specifically.
Is an invite-only script the same as a strategy with backtest results? No. Invite-only describes how a script is distributed; a strategy is a script type whose output can be run through TradingView's Strategy Tester, and either an indicator or a strategy can be published invite-only. A strategy's tester output is produced by the script's own rules on the platform's data, which is a different thing from an independently published calibration record, and neither one follows from the publication mode.
Seeing how a published claim looks on a live chart is the quickest way to judge whether the trade described above is worth making. The Behavioral Transform Model runs as an invite-only script on any TradingView plan, with its construction, calibration record and limits published on the Proof page and in the working paper, and you can start a free 30-day trial to add it to your own charts.
Oisigma provides descriptive market analytics for educational use. It is not investment advice, does not predict prices, and does not provide buy or sell signals. Statistics referenced are historical and were measured in our working paper (not peer-reviewed); past behavior is not a guarantee of future results. Trading and investing involve substantial risk of loss, including the possible loss of all capital invested. Leveraged products (futures, options, margin) carry additional risk and can result in losses that exceed your initial investment. Bollinger Bands® is a registered trademark of John Bollinger; Oisigma is not affiliated with or endorsed by Mr. Bollinger. RiskMetrics® is a registered trademark of MSCI Inc.; Oisigma is not affiliated with or endorsed by MSCI Inc. Nothing in this article is a recommendation to use any particular strategy. Read the full Disclaimer →
Try it free for 30 days and see the range update as new bars print, on whatever symbols and timeframes you actually trade.
30 days free, then $15/mo. Cancel anytime from your account.
Pick up where you left off.